Nelfinavir pharmacokinetics in HIV-infected children: a comparison of twice daily and three times daily dosing
- 1 July 2000
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 14 (10) , 1466-1468
- https://doi.org/10.1097/00002030-200007070-00029
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected childrenAIDS, 1999
- Treatment of Human Immunodeficiency Virus 1‐Infected Infants and Children with the Protease Inhibitor Nelfinavir MesylateClinical Infectious Diseases, 1999
- Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Nelfinavir Mesylate: A Protease InhibitorAnnals of Pharmacotherapy, 1999
- Quantification of the anti‐HIV drug saquinavir by high‐speed on‐line high‐performance liquid chromatography/tandem mass spectrometryJournal of Mass Spectrometry, 1995